United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$216Mraised across 3 rounds since 2025, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Deep Track CapitalLead
Janus Henderson Investors
SR One
British Business Bank
Jefferson Life Sciences
Marshall WaceReported by Jefferson Life Sciences and 1 other
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Draig Therapeutics filed 5 raises, $135M in all. Filings say how much was sold and to how many investors; they never name the investors.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
SR OneSV Health InvestorsDeep Track CapitalL
CanaanJanus Henderson InvestorsBritish Business BankJefferson Life SciencesMarshall WaceMissing a round, or an investor who was in one? Tell us.
Draig Therapeutics's investors include SR One, SV Health Investors, Deep Track Capital, Canaan and Janus Henderson Investors, and 3 more on record. Deep Track Capital led its latest round.
Draig Therapeutics has raised $216M across 3 rounds since 2025.
Draig Therapeutics's most recent round was a Series B of $65M in Jul 2026, led by Deep Track Capital.
Draig Therapeutics's largest round on record is $140M (Series A), in Jun 2025.
Draig Therapeutics's first round on record, in Jun 2025, was backed by Canaan, SR One and SV Health Investors.
Draig Therapeutics's latest named round is a Series B, in Jul 2026.
Draig Therapeutics is based in the United Kingdom.
Deep Track Capital led the Series B in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United Kingdom · 
